نتایج جستجو برای: verifynow

تعداد نتایج: 293  

Journal: :Journal of the American College of Cardiology 2010
Dominick J Angiolillo Jorge F Saucedo Roger Deraad Andrew L Frelinger Paul A Gurbel Timothy M Costigan Joseph A Jakubowski Clement K Ojeh Mark B Effron

OBJECTIVES The objective was to evaluate the pharmacodynamic response of switching patients on maintenance phase clopidogrel therapy after an acute coronary syndrome (ACS) to prasugrel. BACKGROUND Prasugrel P2Y(12) receptor blockade is associated with greater pharmacodynamic platelet inhibition and reduction of ischemic complications compared with that of clopidogrel in ACS patients undergoin...

Journal: :Circulation 2009
Rossella Marcucci Anna Maria Gori Rita Paniccia Betti Giusti Serafina Valente Cristina Giglioli Piergiovanni Buonamici David Antoniucci Rosanna Abbate Gian Franco Gensini

BACKGROUND The clinical impact of platelet aggregation assessed by point-of-care assays is unknown. We sought to evaluate whether high residual platelet reactivity (RPR) to ADP during clopidogrel therapy, measured by a point-of-care assay, predicts adverse clinical events in acute coronary syndrome patients undergoing percutaneous coronary intervention. METHODS AND RESULTS We used the VerifyN...

Journal: :Blood 2011
Fabrice Larosa Eric Deconinck Philippe Helias Jean Fontan Marian Heczko Annie Brion Katell Ledu Philippe Delaby Jacqueline Vuiller Christophe Ferrand Philippe Saas Fabienne Pouthier Anne Dormoy Jacqueline Chabod Caroline Malugani Pierre S Rohrlich Faezeh Legrand

and its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. He is participating in ongoing clinical trials of tolvaptan for the treatment of autosomal dominant polycystic kidney disease sponsored by Otsuka Pharmaceutical Development and Commercialization Inc, and is a consultant to Forest Research Institute Inc and Primrose Th...

Journal: :European Heart Journal 2022

Abstract Objectives This study aimed to determine the prognostic value of serial measurement platelet reactivity (PR) using VerifyNow, P2Y12 reaction unit (PRU) assay following percutaneous coronary intervention (PCI) during antiplatelet therapy. Background On-treatment PR changes over time, but measurements has not been defined. Methods We enrolled 3204 patients who had PCI and were measured a...

Journal: :European Heart Journal Supplements 2022

Abstract Objectives To rule out a drug-drug interaction (DDI) among cangrelor-treated patients who have been pre-treated with ticagrelor. Background There are no studies specifically designed to DDI when cangrelor is used Methods In this prospective, randomized, double-blind, placebo-controlled, cross-over, pharmacokinetic (PK) and pharmacodynamic (PD) study, coronary artery disease (n = 20) we...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید